John Lazarchick to Autoantibodies
This is a "connection" page, showing publications John Lazarchick has written about Autoantibodies.
Connection Strength
0.382
-
Rituximab in the treatment of acquired factor VIII inhibitors. Thromb Haemost. 2006 Jul; 96(1):84-7.
Score: 0.234
-
Platelet-directed antibody in the serum of patients with primary thrombotic thrombocytopenic purpura. Ann Clin Lab Sci. 1987 Sep-Oct; 17(5):339-44.
Score: 0.063
-
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood. 1998 Jun 01; 91(11):4188-96.
Score: 0.033
-
Passive neonatal thrombocytopenia. A case study of factors predicting the response to i.v. IgG therapy. Ann Clin Lab Sci. 1989 Jul-Aug; 19(4):255-9.
Score: 0.018
-
Lupus anticoagulants in children. Ann Clin Lab Sci. 1988 Sep-Oct; 18(5):384-7.
Score: 0.017
-
Detection of platelet antibodies by flow cytometric analysis. Diagn Immunol. 1984; 2(4):238-41.
Score: 0.012
-
Microcytotoxicity assay for platelet antibodies using fresh and frozen fluorescein-labeled target platelets. Diagn Clin Immunol. 1987; 5(2):82-5.
Score: 0.004